📷 Image: Wikimedia Commons / Shealeah Craighead
International
Trump Threatens 200% Tariff on Generic Drug Imports, Impacting India
✍️ NDTV Profit
🗓 26 Jul 2026, 12:05 PM
👁 48
US President Donald Trump has announced a potential 200% tariff on generic drug imports, raising concerns about the impact on India, a major supplier of affordable medicines.
Donald Trump has warned that the United States may impose a 200% tariff on generic drug imports, a move that could disrupt global supply chains.
The proposed tariff would apply to medicines manufactured outside the U.S. and could affect countries that export generics to American consumers.
India, which supplies a large share of affordable drugs to the U.S. market, faces potential revenue losses and supply disruptions if the tariff is enacted.
Analysts say the threat could prompt India to seek alternative markets and strengthen domestic production to mitigate the impact.
The proposed tariff would apply to medicines manufactured outside the U.S. and could affect countries that export generics to American consumers.
India, which supplies a large share of affordable drugs to the U.S. market, faces potential revenue losses and supply disruptions if the tariff is enacted.
Analysts say the threat could prompt India to seek alternative markets and strengthen domestic production to mitigate the impact.